SmithRx filled a $20 million Series B funding round led by leading Silicon Valley firm Venrock with support from Founders Fund, bringing the PBM startup’s valuation to $100 million, Venrock partner Bryan Roberts tells Axios exclusively. Axios
Recent Posts
- The Cru Wants Companies To Tackle Loneliness And Boost Your Career
- Young Love Marriage Pact Gets $5 Million Vote of Confidence from VC
- Brightflow AI aims to spotlight small business cash flow
- Block Party, a tool to combat online harassment, raises a $4.8M seed
- Beyond the Series A and the future of leadership coaching with Christine Tao, CEO and Cofounder of SoundingBoard